Welcome to LookChem.com Sign In|Join Free

CAS

  • or
Fumaric acid is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

110-17-8 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 110-17-8 Structure
  • Basic information

    1. Product Name: Fumaric acid
    2. Synonyms: 2-Butenedioic acid (2E)- (9CI);2-Butenedioic acid (E)-;EPA Pesticide Chemical Code 051201;trans-Butenedioic acid;Allomaleic acid;Boletic acid;(E)-2-Butenedioic acid;1,2-Ethenedicarboxylic acid, trans-;2-(E)-Butenedioic acid;trans-2-Butenedioic acid;FumaricAcid;Fumaric acid (Tech and Food grade);L-Carnitine Fumaric Acid;1, 2-Ethenedicarboxylic acid, trans-;Fumaric acid (NF);2-Butenedioic acid, (E)-;Tumaric acid;Allomalenic acid;Butenedioic acid, (E)-;2-Butenedioic acid;USAF EK-P-583;(2E)-but-2-enedioic acid;Fumaric acid (8CI);Kyselina fumarova;Fumaric acid;
    3. CAS NO:110-17-8
    4. Molecular Formula: C4H4O4
    5. Molecular Weight: 116.08
    6. EINECS: 203-743-0
    7. Product Categories: N/A
    8. Mol File: 110-17-8.mol
  • Chemical Properties

    1. Melting Point: 295-300℃
    2. Boiling Point: 355.5°Cat760mmHg
    3. Flash Point: 230 ºC
    4. Appearance: white powder or colourless crystals
    5. Density: 1.499 g/cm3
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. Water Solubility: 0.63 g/100 mL (25℃)
    10. CAS DataBase Reference: Fumaric acid(CAS DataBase Reference)
    11. NIST Chemistry Reference: Fumaric acid(110-17-8)
    12. EPA Substance Registry System: Fumaric acid(110-17-8)
  • Safety Data

    1. Hazard Codes:  Xi:Irritant;
    2. Statements: R36:;
    3. Safety Statements: S26:;
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 110-17-8(Hazardous Substances Data)

110-17-8 Usage

Chemical Description

Fumaric acid is used to transform the bases into salts.

Check Digit Verification of cas no

The CAS Registry Mumber 110-17-8 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 1,1 and 0 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 110-17:
(5*1)+(4*1)+(3*0)+(2*1)+(1*7)=18
18 % 10 = 8
So 110-17-8 is a valid CAS Registry Number.
InChI:InChI=1/C4H4O4/c5-3(6)1-2-4(7)8/h1-2H,(H,5,6)(H,7,8)/b2-1+

110-17-8 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (A10976)  Fumaric acid, 99%   

  • 110-17-8

  • 500g

  • 196.0CNY

  • Detail
  • Alfa Aesar

  • (A10976)  Fumaric acid, 99%   

  • 110-17-8

  • 2500g

  • 438.0CNY

  • Detail
  • Alfa Aesar

  • (A10976)  Fumaric acid, 99%   

  • 110-17-8

  • 10000g

  • 1729.0CNY

  • Detail
  • Sigma-Aldrich

  • (76635)  Fumaricacid  certified reference material, TraceCERT®

  • 110-17-8

  • 76635-100MG

  • 329.94CNY

  • Detail
  • Sigma-Aldrich

  • (PHR1270)  Fumaric Acid  pharmaceutical secondary standard; traceable to USP, PhEur

  • 110-17-8

  • PHR1270-1G

  • 718.73CNY

  • Detail
  • Sigma-Aldrich

  • (F0600000)  Fumaricacid  European Pharmacopoeia (EP) Reference Standard

  • 110-17-8

  • F0600000

  • 1,880.19CNY

  • Detail
  • USP

  • (1286708)  Fumaricacid  United States Pharmacopeia (USP) Reference Standard

  • 110-17-8

  • 1286708-200MG

  • 4,662.45CNY

  • Detail
  • Vetec

  • (V900245)  Fumaricacid  Vetec reagent grade, 99%

  • 110-17-8

  • V900245-500G

  • 98.28CNY

  • Detail
  • Sigma-Aldrich

  • (47910)  Fumaricacid  ≥99.0% (T)

  • 110-17-8

  • 47910-5G

  • 441.09CNY

  • Detail
  • Sigma-Aldrich

  • (47910)  Fumaricacid  ≥99.0% (T)

  • 110-17-8

  • 47910-25G

  • 497.25CNY

  • Detail
  • Sigma-Aldrich

  • (47910)  Fumaricacid  ≥99.0% (T)

  • 110-17-8

  • 47910-100G

  • 565.11CNY

  • Detail
  • Sigma-Aldrich

  • (47910)  Fumaricacid  ≥99.0% (T)

  • 110-17-8

  • 47910-1KG

  • 703.17CNY

  • Detail

110-17-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 10, 2017

Revision Date: Aug 10, 2017

1.Identification

1.1 GHS Product identifier

Product name fumaric acid

1.2 Other means of identification

Product number -
Other names U-1149

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only. Processing Aids and Additives
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:110-17-8 SDS

110-17-8Synthetic route

maleic acid
110-16-7

maleic acid

(2E)-but-2-enedioic acid
110-17-8

(2E)-but-2-enedioic acid

Conditions
ConditionsYield
With (E)-4-(2-chlorostyryl)pyridine In methanol at 20℃; for 720h;100%
With maleic anhydride In water at 190℃; for 6h; Reagent/catalyst; Inert atmosphere; Autoclave; Green chemistry;99.5%
With N-Bromosuccinimide; dibenzoyl peroxide; acetic acid for 6h; Heating;90%
C13H10ClN*C4H4O4*0.5C4H4O4

C13H10ClN*C4H4O4*0.5C4H4O4

A

1,3-bis(4-pyridyl)-2,4-bis(2-chlorophenyl)cyclobutane

1,3-bis(4-pyridyl)-2,4-bis(2-chlorophenyl)cyclobutane

B

(2E)-but-2-enedioic acid
110-17-8

(2E)-but-2-enedioic acid

Conditions
ConditionsYield
UV-irradiation;A 100%
B n/a
meso-2,3-dibromosuccinic acid
608-36-6

meso-2,3-dibromosuccinic acid

(2E)-but-2-enedioic acid
110-17-8

(2E)-but-2-enedioic acid

Conditions
ConditionsYield
With aluminum oxide for 0.0166667h; microwave irradiation;98%
With sodium tetrahydroborate; nickel dichloride In tetrahydrofuran at 20℃; for 0.75h;89%
With sodium sulfide oder mit aehnlichen Thiosalzen;
(E)-But-2-enedioic acid bis-(1-phenoxy-ethyl) ester

(E)-But-2-enedioic acid bis-(1-phenoxy-ethyl) ester

(2E)-but-2-enedioic acid
110-17-8

(2E)-but-2-enedioic acid

Conditions
ConditionsYield
With trifluoroacetic acid In dichloromethane at 0℃; for 1h;98%
In dichloromethane at 0℃; for 1h; Product distribution; 5percent CF3COOH; other reagent;98%
(+-)-2,3-dibromosuccinic acid
1114-00-7

(+-)-2,3-dibromosuccinic acid

(2E)-but-2-enedioic acid
110-17-8

(2E)-but-2-enedioic acid

Conditions
ConditionsYield
With aluminum oxide for 0.0166667h; microwave irradiation;98%
With sodium tetrahydroborate; nickel dichloride In tetrahydrofuran at 20℃; for 1h;90%
malic acid
617-48-1

malic acid

(2E)-but-2-enedioic acid
110-17-8

(2E)-but-2-enedioic acid

Conditions
ConditionsYield
96%
In neat (no solvent) at 200℃; for 4h; Inert atmosphere;96.6%
at 180℃; for 4h; Temperature; Inert atmosphere;88%
C22H18O10

C22H18O10

A

(2E)-but-2-enedioic acid
110-17-8

(2E)-but-2-enedioic acid

B

4,6-dimethoxyanthracene-1,2-dicarboxylic anhydride

4,6-dimethoxyanthracene-1,2-dicarboxylic anhydride

Conditions
ConditionsYield
In diphenylether Heating;A n/a
B 94%
C21H16O9

C21H16O9

A

(2E)-but-2-enedioic acid
110-17-8

(2E)-but-2-enedioic acid

B

4-methoxyanthracene-1,2-dicarboxylic anhydride

4-methoxyanthracene-1,2-dicarboxylic anhydride

Conditions
ConditionsYield
In diphenylether Heating;A n/a
B 90%
trisodium tris(3-sulfophenyl)phosphine
63995-70-0

trisodium tris(3-sulfophenyl)phosphine

Acetylenedicarboxylic acid
142-45-0

Acetylenedicarboxylic acid

A

tris(natrium-m-sulfonatophenyl)phosphanoxid
98511-67-2

tris(natrium-m-sulfonatophenyl)phosphanoxid

B

(2E)-but-2-enedioic acid
110-17-8

(2E)-but-2-enedioic acid

Conditions
ConditionsYield
In water for 5h; Ambient temperature;A n/a
B 87%
maleic acid
110-16-7

maleic acid

A

tetrahydrofuran
109-99-9

tetrahydrofuran

B

4-butanolide
96-48-0

4-butanolide

C

Butane-1,4-diol
110-63-4

Butane-1,4-diol

D

4-hydroxybutanoic acid
591-81-1

4-hydroxybutanoic acid

E

malic acid
617-48-1

malic acid

F

succinic acid
110-15-6

succinic acid

G

terephthalic acid
100-21-0

terephthalic acid

H

acetic acid
64-19-7

acetic acid

I

propionic acid
802294-64-0

propionic acid

J

(2E)-but-2-enedioic acid
110-17-8

(2E)-but-2-enedioic acid

Conditions
ConditionsYield
With hydrogen; 0.5percent Pd/0.2percent Re on Rutile TiO2 at 110℃; for 170 - 1009h; Product distribution / selectivity;A 0.86%
B 4.34%
C 0.28%
D 1.24%
E 0%
F 85.51%
G 0%
H 0.04%
I 0%
J 0%
C19H14O6

C19H14O6

A

2-anthroic acid
613-08-1

2-anthroic acid

B

(2E)-but-2-enedioic acid
110-17-8

(2E)-but-2-enedioic acid

Conditions
ConditionsYield
In diphenylether Heating;A 84%
B n/a
maleic anhydride
108-31-6

maleic anhydride

(2E)-but-2-enedioic acid
110-17-8

(2E)-but-2-enedioic acid

Conditions
ConditionsYield
With thiourea In water at 25 - 30℃;83.6%
With hydrogenchloride
With water; thiourea
Stage #1: maleic anhydride With water at 45 - 50℃; for 2.25h;
Stage #2: With thiourea at 45 - 50℃; for 1h;
290 g
carbon monoxide
201230-82-2

carbon monoxide

acetylene
74-86-2

acetylene

A

succinic acid
110-15-6

succinic acid

B

(2E)-but-2-enedioic acid
110-17-8

(2E)-but-2-enedioic acid

Conditions
ConditionsYield
With 8-nitroquinoline; water; hydrogen bromide; lithium bromide; palladium(II) bromide In acetonitrile at 30℃; for 4.26667h; Reagent/catalyst; Temperature; Overall yield = 2.56 g;A 80.27%
B 17.12%
(R)-4,4,4-trichloro-3-hydroxybutanoic acid
80513-23-1

(R)-4,4,4-trichloro-3-hydroxybutanoic acid

A

D-Malic acid
636-61-3

D-Malic acid

B

(2E)-but-2-enedioic acid
110-17-8

(2E)-but-2-enedioic acid

Conditions
ConditionsYield
With sodium hydroxide In water at 20℃; for 24h;A 79%
B n/a
(+/-)-9,10-ethanoanthracene-2,3,trans-11,12-tetracarboxylic acid

(+/-)-9,10-ethanoanthracene-2,3,trans-11,12-tetracarboxylic acid

A

2,3-anthracenedicarboxylic acid anhydride
6812-14-2

2,3-anthracenedicarboxylic acid anhydride

B

(2E)-but-2-enedioic acid
110-17-8

(2E)-but-2-enedioic acid

Conditions
ConditionsYield
In diphenylether Heating;A 79%
B n/a
maleic anhydride
108-31-6

maleic anhydride

2-allyloxy-2-phenylethan-1-ol
75455-48-0

2-allyloxy-2-phenylethan-1-ol

A

mono(2-allyloxy-2-phenylethyl) fumarate

mono(2-allyloxy-2-phenylethyl) fumarate

B

(2E)-but-2-enedioic acid
110-17-8

(2E)-but-2-enedioic acid

Conditions
ConditionsYield
Stage #1: maleic anhydride; 2-allyloxy-2-phenylethan-1-ol With 4-methoxy-phenol In toluene at 130℃; for 5h;
Stage #2: With hydrogenchloride In water; toluene at 130℃; for 10h;
A 75.1%
B n/a
(E)-but-2-enoic acid
107-93-7

(E)-but-2-enoic acid

(2E)-but-2-enedioic acid
110-17-8

(2E)-but-2-enedioic acid

Conditions
ConditionsYield
With sodium hypochlorite; nickel dichloride In dichloromethane; water at 0 - 20℃; for 4h;75%
tartaric acid
87-69-4

tartaric acid

A

glycolic Acid
79-14-1

glycolic Acid

B

(2E)-but-2-enedioic acid
110-17-8

(2E)-but-2-enedioic acid

Conditions
ConditionsYield
With oxygen In water at 160℃; under 13680.9 Torr; for 10h; Reagent/catalyst;A 27%
B 73%
maleic anhydride
108-31-6

maleic anhydride

A

malic acid
617-48-1

malic acid

B

(2E)-but-2-enedioic acid
110-17-8

(2E)-but-2-enedioic acid

Conditions
ConditionsYield
With water at 190℃; for 1h; Temperature; Concentration; Time; Sealed tube; Green chemistry;A n/a
B 72%
(S)-Malic acid
97-67-6

(S)-Malic acid

(2E)-but-2-enedioic acid
110-17-8

(2E)-but-2-enedioic acid

Conditions
ConditionsYield
With toluene-4-sulfonic acid at 120℃;71%
With propan-1-ol Bei der Einw. von Bact. coli unter anaeroben Bedingungen;
bei der Einw. von Muskelextrakt oder Muskelbrei;
(2E)-but-2-enedioic acid
110-17-8

(2E)-but-2-enedioic acid

Conditions
ConditionsYield
With copper; copper(II) perchlorate In methanol for 2h; Ambient temperature;71%
With sodium sulfide oder mit aehnlichen Thiosalzen;
With sodium thioethylate oder mit aehnlichen Thiosalzen;
d,l-dibromo succinic acid
526-78-3, 608-35-5, 608-36-6, 1114-00-7

d,l-dibromo succinic acid

(2E)-but-2-enedioic acid
110-17-8

(2E)-but-2-enedioic acid

Conditions
ConditionsYield
With copper; copper(II) perchlorate In methanol for 3.5h; Ambient temperature;70%
(S)-3,4-Epoxybutyric Acid
33278-09-0

(S)-3,4-Epoxybutyric Acid

(2E)-but-2-enedioic acid
110-17-8

(2E)-but-2-enedioic acid

Conditions
ConditionsYield
With sodium hypochlorite; nickel dichloride In dichloromethane; water at 0 - 20℃; for 4h;69%
tartaric acid
87-69-4

tartaric acid

A

glycolic Acid
79-14-1

glycolic Acid

B

LACTIC ACID
849585-22-4

LACTIC ACID

C

(2E)-but-2-enedioic acid
110-17-8

(2E)-but-2-enedioic acid

Conditions
ConditionsYield
With oxygen In water at 160℃; under 13680.9 Torr; for 10h;A 69%
B 7%
C 24%
furfural
98-01-1

furfural

A

2-furanoic acid
88-14-2

2-furanoic acid

B

succinic acid
110-15-6

succinic acid

C

maleic acid
110-16-7

maleic acid

D

(2E)-but-2-enedioic acid
110-17-8

(2E)-but-2-enedioic acid

Conditions
ConditionsYield
With dihydrogen peroxide; 1-butyl-3-methylimidazolium Tetrafluoroborate; methyltrioxorhenium(VII) In water at 20℃;A 7%
B 12%
C 66%
D 13%
furfural
98-01-1

furfural

A

maleic acid
110-16-7

maleic acid

B

(2E)-but-2-enedioic acid
110-17-8

(2E)-but-2-enedioic acid

Conditions
ConditionsYield
With dihydrogen peroxide; acidine In water at 100℃; for 0.5h; Temperature;A 61%
B 31%
With dihydrogen peroxide; acidine In water at 100℃; for 2h; Time;A 10%
B 48%
With sodium chlorate; vanadium pentoxide In water at 85 - 95℃; for 19h;A n/a
B 47%
With sodium chlorate; vanadia In water at 80 - 90℃; for 13h; Overall yield = 58 %; Overall yield = 42.3 g;A n/a
B n/a
With choline chloride; dihydrogen peroxide; oxalic acid In water at 50℃; for 24h; Reagent/catalyst; Green chemistry; Overall yield = 95.7 %Chromat.;
malic acid
617-48-1

malic acid

A

maleic acid
110-16-7

maleic acid

B

(2E)-but-2-enedioic acid
110-17-8

(2E)-but-2-enedioic acid

C

acrylic acid
79-10-7

acrylic acid

Conditions
ConditionsYield
sodium hydroxide In water at 340℃; under 129290 Torr; pH=3.17; Product distribution / selectivity;A 10.52%
B 6.88%
C 59.23%
toluene-4-sulfonamide
70-55-3

toluene-4-sulfonamide

diethyl Fumarate
623-91-6

diethyl Fumarate

A

p-toluenesulfonamidosuccinic acid ethyl ester
104830-35-5

p-toluenesulfonamidosuccinic acid ethyl ester

B

(2E)-but-2-enedioic acid
110-17-8

(2E)-but-2-enedioic acid

Conditions
ConditionsYield
With potassium hydroxide In neat (no solvent) at 53℃; for 1h; Michael Addition; Sonication;A 50%
B n/a
malic acid
617-48-1

malic acid

A

succinic acid
110-15-6

succinic acid

B

(2E)-but-2-enedioic acid
110-17-8

(2E)-but-2-enedioic acid

Conditions
ConditionsYield
With hydrogen iodide; propionic acid at 160℃; under 25858.1 Torr; for 2h; Kinetics; Inert atmosphere;A 46%
B 10%
cyclopenta-1,3-diene
542-92-7

cyclopenta-1,3-diene

(2E)-but-2-enedioic acid
110-17-8

(2E)-but-2-enedioic acid

norbornene-5,6-dicarboxylic acid
1200-88-0

norbornene-5,6-dicarboxylic acid

Conditions
ConditionsYield
In water; acetone at 50℃; for 24h; Diels-Alder Cycloaddition;100%
In 1,4-dioxane at 60℃; for 1h;94%
With N,N-dimethyl-formamide andere polare Loesungsmittel;
(2E)-but-2-enedioic acid
110-17-8

(2E)-but-2-enedioic acid

2-(3-phthalimidopropyl)-8H-indeno[1,2-d]thiazole
172259-74-4

2-(3-phthalimidopropyl)-8H-indeno[1,2-d]thiazole

2-(3-aminopropyl)-8H-indeno[1,2-d]thiazole fumarate

2-(3-aminopropyl)-8H-indeno[1,2-d]thiazole fumarate

Conditions
ConditionsYield
Stage #1: 2-(3-phthalimidopropyl)-8H-indeno[1,2-d]thiazole With methylamine In methanol at 20℃; for 16h;
Stage #2: (2E)-but-2-enedioic acid In methanol
100%
(+)-N-(3-amino-propyl)-N-[(R)-1-(6-benzyl-3-chloro-2-methyl-7-oxo-6,7-dihydro-pyrazolo[1,5-c]pyrimidin-5-yl)-2-methyl-propyl]-4-methyl-benzamide hydrochloride

(+)-N-(3-amino-propyl)-N-[(R)-1-(6-benzyl-3-chloro-2-methyl-7-oxo-6,7-dihydro-pyrazolo[1,5-c]pyrimidin-5-yl)-2-methyl-propyl]-4-methyl-benzamide hydrochloride

(2E)-but-2-enedioic acid
110-17-8

(2E)-but-2-enedioic acid

N-(3-amino-propyl)-N-[(R)-1-(6-benzyl-3-chloro-2-methyl-7-oxo-6,7-dihydro-pyrazolo[1,5-c]pyrimidin-5-yl)-2-methyl-propyl]-4-methyl-benzamide fumarate

N-(3-amino-propyl)-N-[(R)-1-(6-benzyl-3-chloro-2-methyl-7-oxo-6,7-dihydro-pyrazolo[1,5-c]pyrimidin-5-yl)-2-methyl-propyl]-4-methyl-benzamide fumarate

Conditions
ConditionsYield
In ethanol for 0.116667h; Heating / reflux;100%
(2E)-but-2-enedioic acid
110-17-8

(2E)-but-2-enedioic acid

dihydro-2(3H)furanone-[3,4,5,5-D4]

dihydro-2(3H)furanone-[3,4,5,5-D4]

Conditions
ConditionsYield
With deuterium; Ru4H4(CO)8(PBu3)4 In tetrahydrofuran at 180℃; for 48h;100%
(1R,5S)-3-methyl-6-(6-phenyl-pyridazin-3-yl)-3,6-diaza-bicyclo[3.2.0]heptane

(1R,5S)-3-methyl-6-(6-phenyl-pyridazin-3-yl)-3,6-diaza-bicyclo[3.2.0]heptane

(2E)-but-2-enedioic acid
110-17-8

(2E)-but-2-enedioic acid

(1R,5S)-3-methyl-6-(6-phenyl-pyridazin-3-yl)-3,6-diaza-bicyclo[3.2.0]heptane fumarate

(1R,5S)-3-methyl-6-(6-phenyl-pyridazin-3-yl)-3,6-diaza-bicyclo[3.2.0]heptane fumarate

Conditions
ConditionsYield
In methanol; ethyl acetate at 20℃; for 18h;100%
(1RS,3aRS)-1-[1-(2,3,3a,4,5,6-hexahydro-1H-phenalen-1-yl)piperidin-4-yl]-1,3-dihydro-2H-benzimidazol-2-one

(1RS,3aRS)-1-[1-(2,3,3a,4,5,6-hexahydro-1H-phenalen-1-yl)piperidin-4-yl]-1,3-dihydro-2H-benzimidazol-2-one

(2E)-but-2-enedioic acid
110-17-8

(2E)-but-2-enedioic acid

C4H4O4*C25H29N3O

C4H4O4*C25H29N3O

Conditions
ConditionsYield
In ethanol100%
(2E)-but-2-enedioic acid
110-17-8

(2E)-but-2-enedioic acid

(R)-2-[3-(diisopropylamino)-1-phenylpropyl]-4-(hydroxymethyl)-phenol
207679-81-0

(R)-2-[3-(diisopropylamino)-1-phenylpropyl]-4-(hydroxymethyl)-phenol

(R)-5-hydroxymethyl tolterodine fumarate salt
380636-50-0

(R)-5-hydroxymethyl tolterodine fumarate salt

Conditions
ConditionsYield
In acetone at 20℃; for 0.5h;100%
In acetone at 25 - 30℃; for 1h;2.4 g
3-[6-(1H-indol-3-yl)-pyridazin-3-yloxy]-1-aza-bicyclo[2.2.2]octane
855738-90-8

3-[6-(1H-indol-3-yl)-pyridazin-3-yloxy]-1-aza-bicyclo[2.2.2]octane

(2E)-but-2-enedioic acid
110-17-8

(2E)-but-2-enedioic acid

3-[6-(1H-indol-3-yl)-pyridazin-3-yloxy]-1-aza-bicyclo[2.2.2]octane hemifumarate

3-[6-(1H-indol-3-yl)-pyridazin-3-yloxy]-1-aza-bicyclo[2.2.2]octane hemifumarate

Conditions
ConditionsYield
In methanol; ethyl acetate at 20℃;100%
N-[2-[2-[4-[(3RS)-1-azabicyclo[2.2.2]oct-3-yl]-1-piperazinyl]-2-oxo-ethoxy]ethyl]-4-methoxy-N,2,6-trimethylbenzene-sulphonamide
766558-09-2

N-[2-[2-[4-[(3RS)-1-azabicyclo[2.2.2]oct-3-yl]-1-piperazinyl]-2-oxo-ethoxy]ethyl]-4-methoxy-N,2,6-trimethylbenzene-sulphonamide

(2E)-but-2-enedioic acid
110-17-8

(2E)-but-2-enedioic acid

N-[2-[2-[4-[(3RS)-1-azabicyclo[2.2.2]oct-3-yl]-1-piperazinyl]-2-oxo-ethoxy]ethyl]-4-methoxy-N,2,6-trimethylbenzene-sulphonamide difumarate

N-[2-[2-[4-[(3RS)-1-azabicyclo[2.2.2]oct-3-yl]-1-piperazinyl]-2-oxo-ethoxy]ethyl]-4-methoxy-N,2,6-trimethylbenzene-sulphonamide difumarate

Conditions
ConditionsYield
In methanol for 0.5h;100%
2-[((2S)-1'-{2-[(2R)-4-[3,5-bis(trifluoromethyl)benzoyl]-2-(3,4-dichlorophenyl)morpholin-2-yl]ethyl}-2,3-dihydrospiro[indene-1,4'-piperidin]-2-yl)oxy]-N-(4-hydroxybutyl)-N-methylacetamide
863613-79-0

2-[((2S)-1'-{2-[(2R)-4-[3,5-bis(trifluoromethyl)benzoyl]-2-(3,4-dichlorophenyl)morpholin-2-yl]ethyl}-2,3-dihydrospiro[indene-1,4'-piperidin]-2-yl)oxy]-N-(4-hydroxybutyl)-N-methylacetamide

(2E)-but-2-enedioic acid
110-17-8

(2E)-but-2-enedioic acid

2-[((2S)-1'-{2-[(2R)-4-[3,5-bis(Trifluoromethyl)benzoyl]-2-(3,4-dichlorophenyl)morpholin-2-yl]ethyl}-2,3-dihydrospiro[indene-1,4'-piperidin]-2-yl)oxy]-N-(4-hydroxybutyl)-N-methylacetamide fumarate

2-[((2S)-1'-{2-[(2R)-4-[3,5-bis(Trifluoromethyl)benzoyl]-2-(3,4-dichlorophenyl)morpholin-2-yl]ethyl}-2,3-dihydrospiro[indene-1,4'-piperidin]-2-yl)oxy]-N-(4-hydroxybutyl)-N-methylacetamide fumarate

Conditions
ConditionsYield
In ethanol100%
4,4'-bipyridine
553-26-4

4,4'-bipyridine

zinc diacetate
557-34-6

zinc diacetate

(2E)-but-2-enedioic acid
110-17-8

(2E)-but-2-enedioic acid

[Zn2(fumarate)2(4,4'-bipyridyl)]n

[Zn2(fumarate)2(4,4'-bipyridyl)]n

Conditions
ConditionsYield
100%
1-[1-(toluene-4-sulfonyl)-1H-indol-5-yl]-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepine
1198187-79-9

1-[1-(toluene-4-sulfonyl)-1H-indol-5-yl]-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepine

(2E)-but-2-enedioic acid
110-17-8

(2E)-but-2-enedioic acid

1-(1H-indol-5-yl)-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepine fumarate
1198187-81-3

1-(1H-indol-5-yl)-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepine fumarate

Conditions
ConditionsYield
Stage #1: 1-[1-(toluene-4-sulfonyl)-1H-indol-5-yl]-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepine With sodium ethanolate In ethanol for 2h; Reflux;
Stage #2: (2E)-but-2-enedioic acid In ethanol
100%
(2S,5R)-3-bromo-5-pyrrolidin-2-yl-4,5-dihydroisoxazole
1262011-69-7

(2S,5R)-3-bromo-5-pyrrolidin-2-yl-4,5-dihydroisoxazole

(2E)-but-2-enedioic acid
110-17-8

(2E)-but-2-enedioic acid

(2S,5R)-3-bromo-5-pyrrolidin-2-yl-4,5-dihydroisoxazole fumarate
1262011-74-4

(2S,5R)-3-bromo-5-pyrrolidin-2-yl-4,5-dihydroisoxazole fumarate

Conditions
ConditionsYield
In methanol at 20℃; for 16h;100%
Bisegliptin

Bisegliptin

(2E)-but-2-enedioic acid
110-17-8

(2E)-but-2-enedioic acid

(2S,4S)-1-[2-[(4-ethoxycarbonylbicyclo[2.2.2]oct-1-yl)amino]acetyl]-4-fluoropyrrolidine-2-carbonitrile fumarate
1218908-87-2

(2S,4S)-1-[2-[(4-ethoxycarbonylbicyclo[2.2.2]oct-1-yl)amino]acetyl]-4-fluoropyrrolidine-2-carbonitrile fumarate

Conditions
ConditionsYield
In acetone at 45℃; for 0.5h; Product distribution / selectivity;100%
N-(3,4-Dichloro-phenyl)-N-ethyl-3-piperidin-4-yl-propionamide
1212022-70-2

N-(3,4-Dichloro-phenyl)-N-ethyl-3-piperidin-4-yl-propionamide

(2E)-but-2-enedioic acid
110-17-8

(2E)-but-2-enedioic acid

N-(3,4-dichloro-phenyl)-N-ethyl-3-piperidin-4-yl-propionamide fumarate

N-(3,4-dichloro-phenyl)-N-ethyl-3-piperidin-4-yl-propionamide fumarate

Conditions
ConditionsYield
In methanol; dichloromethane100%
meloxicam
71125-38-7

meloxicam

(2E)-but-2-enedioic acid
110-17-8

(2E)-but-2-enedioic acid

C4H4O4*2C14H13N3O4S2

C4H4O4*2C14H13N3O4S2

Conditions
ConditionsYield
In tetrahydrofuran for 0.5h;100%
(1S,2S,4S)-4-(2-carbamoyl-2-methylpropyl-carbamoyl)-2-hydroxy-1-{(S)-2-[4-methoxy-3-(3-methoxypropoxy)-benzyl]-3-methylbutyl}-5-methylhexyl-carbamic acid benzyl ester
1236549-06-6

(1S,2S,4S)-4-(2-carbamoyl-2-methylpropyl-carbamoyl)-2-hydroxy-1-{(S)-2-[4-methoxy-3-(3-methoxypropoxy)-benzyl]-3-methylbutyl}-5-methylhexyl-carbamic acid benzyl ester

(2E)-but-2-enedioic acid
110-17-8

(2E)-but-2-enedioic acid

(2S,4S,5S,7S)-5-amino-N-(3-amino-2,2-dimethyl-3-oxypropyl)-4-hydroxy-7-[[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl]-8-methyl-(2-propan-2-yl)nonanamide hemifumarate
173334-58-2

(2S,4S,5S,7S)-5-amino-N-(3-amino-2,2-dimethyl-3-oxypropyl)-4-hydroxy-7-[[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl]-8-methyl-(2-propan-2-yl)nonanamide hemifumarate

Conditions
ConditionsYield
Stage #1: (1S,2S,4S)-4-(2-carbamoyl-2-methylpropyl-carbamoyl)-2-hydroxy-1-{(S)-2-[4-methoxy-3-(3-methoxypropoxy)-benzyl]-3-methylbutyl}-5-methylhexyl-carbamic acid benzyl ester With palladium 10% on activated carbon; hydrogen In isopropyl alcohol at 20℃; under 760.051 Torr;
Stage #2: (2E)-but-2-enedioic acid In ethanol
100%
Stage #1: (1S,2S,4S)-4-(2-carbamoyl-2-methylpropyl-carbamoyl)-2-hydroxy-1-{(S)-2-[4-methoxy-3-(3-methoxypropoxy)-benzyl]-3-methylbutyl}-5-methylhexyl-carbamic acid benzyl ester With palladium 10% on activated carbon In isopropyl alcohol at 20℃; under 760.051 Torr;
Stage #2: (2E)-but-2-enedioic acid In ethanol
85%
C7H13N3O2S
1579943-67-1

C7H13N3O2S

(2E)-but-2-enedioic acid
110-17-8

(2E)-but-2-enedioic acid

2-(4-methoxy-1,2,5-thiadiazol-3-yloxy)-N,N-dimethylethanamine fumarate
1580000-49-2

2-(4-methoxy-1,2,5-thiadiazol-3-yloxy)-N,N-dimethylethanamine fumarate

Conditions
ConditionsYield
In ethanol Inert atmosphere;100%
(R)-6-methylamino-2-methylheptene
1620401-56-0

(R)-6-methylamino-2-methylheptene

(2E)-but-2-enedioic acid
110-17-8

(2E)-but-2-enedioic acid

(R)-isometheptene fumarate

(R)-isometheptene fumarate

Conditions
ConditionsYield
In ethanol at -20℃; Solvent; Temperature;100%
dispirocyclopropyldehydrocostus lactone
1403389-47-8

dispirocyclopropyldehydrocostus lactone

N,N-dimethylammonium chloride
506-59-2

N,N-dimethylammonium chloride

(2E)-but-2-enedioic acid
110-17-8

(2E)-but-2-enedioic acid

dispirocyclopropyldehydrocostus lactone

dispirocyclopropyldehydrocostus lactone

Conditions
ConditionsYield
Stage #1: dispirocyclopropyldehydrocostus lactone; N,N-dimethylammonium chloride With potassium carbonate In dichloromethane for 4h; Reflux;
Stage #2: (2E)-but-2-enedioic acid In methanol for 0.5h;
100%
1-{2-[3-(tert-butylamino)-2-hydroxypropoxy]-5-(methoxymethyl)phenyl}ethanone

1-{2-[3-(tert-butylamino)-2-hydroxypropoxy]-5-(methoxymethyl)phenyl}ethanone

(2E)-but-2-enedioic acid
110-17-8

(2E)-but-2-enedioic acid

1-{2-[3-(tert-butylamino)-2-hydroxypropoxy]-5-(methoxymethyl)phenyl}ethanone, fumarate salt

1-{2-[3-(tert-butylamino)-2-hydroxypropoxy]-5-(methoxymethyl)phenyl}ethanone, fumarate salt

Conditions
ConditionsYield
In diethyl ether100%
1-{2-[3-(tert-butylamino)-2-hydroxypropoxy]-5-(ethoxymethyl)phenyl}ethanone

1-{2-[3-(tert-butylamino)-2-hydroxypropoxy]-5-(ethoxymethyl)phenyl}ethanone

(2E)-but-2-enedioic acid
110-17-8

(2E)-but-2-enedioic acid

1-{2-[3-(tert-butylamino)-2-hydroxypropoxy]-5-(ethoxymethyl)phenyl}ethanone, fumarate salt

1-{2-[3-(tert-butylamino)-2-hydroxypropoxy]-5-(ethoxymethyl)phenyl}ethanone, fumarate salt

Conditions
ConditionsYield
In diethyl ether100%
1-[5-(ethoxymethyl)-2-(2-hydroxy-3-(isopropylamino)propoxy)-phenyl]ethanone

1-[5-(ethoxymethyl)-2-(2-hydroxy-3-(isopropylamino)propoxy)-phenyl]ethanone

(2E)-but-2-enedioic acid
110-17-8

(2E)-but-2-enedioic acid

1-[5-(ethoxymethyl)-2-(2-hydroxy-3-(isopropylamino)propoxy)-phenyl]ethanone, fumarate salt

1-[5-(ethoxymethyl)-2-(2-hydroxy-3-(isopropylamino)propoxy)-phenyl]ethanone, fumarate salt

Conditions
ConditionsYield
In diethyl ether100%
(2E)-but-2-enedioic acid
110-17-8

(2E)-but-2-enedioic acid

1-{2-[3-(tert-butylamino)-2-hydroxypropoxy]-5-(propoxymethyl)phenyl}ethanone

1-{2-[3-(tert-butylamino)-2-hydroxypropoxy]-5-(propoxymethyl)phenyl}ethanone

1-{2-[3-(tert-butylamino)-2-hydroxypropoxy]-5-(propoxymethyl)phenyl}ethanone, fumarate salt

1-{2-[3-(tert-butylamino)-2-hydroxypropoxy]-5-(propoxymethyl)phenyl}ethanone, fumarate salt

Conditions
ConditionsYield
In diethyl ether100%
(2E)-but-2-enedioic acid
110-17-8

(2E)-but-2-enedioic acid

1-{2-[2-hydroxy-3-(isopropylamino)propoxy]-5-(propoxymethyl)phenyl}ethanone

1-{2-[2-hydroxy-3-(isopropylamino)propoxy]-5-(propoxymethyl)phenyl}ethanone

1-{2-[2-hydroxy-3-(isopropylamino)propoxy]-5-(propoxymethyl)phenyl}ethanone, fumarate salt

1-{2-[2-hydroxy-3-(isopropylamino)propoxy]-5-(propoxymethyl)phenyl}ethanone, fumarate salt

Conditions
ConditionsYield
In diethyl ether100%
1-{2-[3-(tert-butylamino)-2-hydroxypropoxy]-5-(isopropoxymethyl)phenyl}ethanone

1-{2-[3-(tert-butylamino)-2-hydroxypropoxy]-5-(isopropoxymethyl)phenyl}ethanone

(2E)-but-2-enedioic acid
110-17-8

(2E)-but-2-enedioic acid

1-{2-[3-(tert-butylamino)-2-hydroxypropoxy]-5-(isopropoxymethyl)phenyl}ethanone, fumarate salt

1-{2-[3-(tert-butylamino)-2-hydroxypropoxy]-5-(isopropoxymethyl)phenyl}ethanone, fumarate salt

Conditions
ConditionsYield
In diethyl ether100%
1-{5-(butoxymethyl)-2-[3-(tert-butylamino)-2-hydroxypropoxy]phenyl}ethanone

1-{5-(butoxymethyl)-2-[3-(tert-butylamino)-2-hydroxypropoxy]phenyl}ethanone

(2E)-but-2-enedioic acid
110-17-8

(2E)-but-2-enedioic acid

1-{5-(butoxymethyl)-2-[3-(tert-butylamino)-2-hydroxypropoxy]phenyl}ethanone, fumarate salt

1-{5-(butoxymethyl)-2-[3-(tert-butylamino)-2-hydroxypropoxy]phenyl}ethanone, fumarate salt

Conditions
ConditionsYield
In diethyl ether100%
1-{2-[3-(tert-butylamino)-2-hydroxypropoxy]-5-(pentyloxymethyl)phenyl}ethanone

1-{2-[3-(tert-butylamino)-2-hydroxypropoxy]-5-(pentyloxymethyl)phenyl}ethanone

(2E)-but-2-enedioic acid
110-17-8

(2E)-but-2-enedioic acid

1-{2-[3-(tert-butylamino)-2-hydroxypropoxy]-5-(pentyloxymethyl)phenyl}ethanone, fumarate salt

1-{2-[3-(tert-butylamino)-2-hydroxypropoxy]-5-(pentyloxymethyl)phenyl}ethanone, fumarate salt

Conditions
ConditionsYield
In diethyl ether100%

110-17-8Related news

Ultrasound treatment combined with Fumaric acid (cas 110-17-8) for inactivating food-borne pathogens in apple juice and its mechanisms08/21/2019

The purpose of this study was to evaluate the synergistic bactericidal efficacy of combining ultrasound (US) and fumaric acid (FA) treatment against Escherichia coli O157:H7, Salmonella Typhimurium, and Listeria monocytogenes in apple juice and to identify the synergistic bactericidal mechanisms...detailed

Separation of Fumaric acid (cas 110-17-8) by amine extraction without and with 1-octanol as phase modifier08/20/2019

The aim of the current experiments was to study the reactive extraction of fumaric acid using Amberlite LA-2 and to comparatively analyze the influences of the process parameters (pH-value of aqueous phase, extractant concentration, and organic phase polarity) on the separation performances for ...detailed

110-17-8Relevant articles and documents

Production of Plant Phthalate and its Hydrogenated Derivative from Bio-Based Platform Chemicals

Lu, Rui,Lu, Fang,Si, Xiaoqin,Jiang, Huifang,Huang, Qianqian,Yu, Weiqiang,Kong, Xiangtao,Xu, Jie

, p. 1621 - 1627 (2018)

Direct transformation of bio-based platform chemicals into aromatic dicarboxylic acids and their derivatives, which are widely used for the manufacture of polymers, is of significant importance for the sustainable development of the plastics industry. However, limited successful chemical processes have been reported. This study concerns a sustainable route for the production of phthalate and its hydrogenated derivative from bio-based malic acid and erythritol. The key Diels–Alder reaction is applied to build a substituted cyclohexene structure. The dehydration reaction of malic acid affords fumaric acid with 96.6 % yield, which could be used as the dienophile, and 1,3-butadiene generated in situ through erythritol deoxydehydration serves as the diene. Starting from erythritol and dibutyl fumarate, a 74.3 % yield of dibutyl trans-4-cyclohexene-1,2-dicarboxylate is obtained. The palladium-catalyzed dehydrogenation of the cycloadduct gives a 77.8 % yield of dibutyl phthalate. Dibutyl trans-cyclohexane-1,2-dicarboxylate could be formed in nearly 100 % yield under mild conditions by hydrogenation of the cycloadduct. Furthermore, fumaric acid and fumarate, with trans configurations, were found to be better dienophiles for this Diels–Alder reaction than maleic acid and maleate, with cis configuration, based on the experimental and computational results. This new route will pave the way for the production of environmental friendly plastic materials from plants.

An efficient and practical system for the catalytic oxidation of alcohols, aldehydes, and α,β-unsaturated carboxylic acids

Grill, Joseph M.,Ogle, James W.,Miller, Stephen A.

, p. 9291 - 9296 (2006)

(Chemical Equation Presented) Upon exposure to commercial bleach (~5% aqueous sodium hypochlorite), nickel(II) chloride or nickel(II) acetate is transformed quantitatively into an insoluble nickel species, nickel oxide hydroxide. This material consists of high surface area nanoparticles (ca. 4 nm) and is a useful heterogeneous catalyst for the oxidation of many organic compounds. The oxidation of primary alcohols to carboxylic acids, secondary alcohols to ketones, aldehydes to carboxylic acids, and α,β- unsaturated carboxylic acids to epoxy acids is demonstrated using 2.5 mol % of nickel catalyst and commercial bleach as the terminal oxidant. We demonstrate the controlled and selective oxidation of several organic substrates using this system affording 70-95% isolated yields and 90-100% purity. In most cases, the oxidations can be performed without an organic solvent, making this approach attractive as a "greener" alternative to conventional oxidations.

TAN-1323 C and D, new concanamycin-group antibiotics; Detection of the angiostatic activity with a wide range of macrolide antibiotics

Ishii,Hida,Iinuma,Muroi,Nozaki

, p. 12 - 20 (1995)

We detected potent angiostatic activity in a MrOH extract from the mycelia of microbial strain S-45628 in the chick chorioallantoic membrane (CAM) assay. The producer was taxonomically characterized as Streptomyces purpurascens. Active principles designated TAN-1323 A~D were isolated and determined to be 18-membered macrolide antibiotics; components C and D are new members of this group, while components A and B are identical to concansmycins C and A, respectively. When tested in the CAM assay, components B and D gave huge avascular zones at the extremely low doses of 10~100ng/disk, although components A and C showed far weaker activity due to their preferential tissue-damaging effect on the CAM. The discovery that these 18-membered macrolide antibiotics are angiostatic substances prompted us to examine other types of macrolide antibiotics, leading to the discovery that 18-membered macrolide antibiotics such as bafilomycin C1, tylosin and leucomycin also show angiostatic activity on the CAM. Thus, angiostatic potential is widely distributed among macrolide antibiotics. The mechanism of action of these macrolide antibiotics is also discussed.

Potent covalent inhibitors of bacterial urease identified by activity-reactivity profiling

Macegoniuk, Katarzyna,Kowalczyk, Rafa?,Rudzińska, Anna,Psurski, Mateusz,Wietrzyk, Joanna,Berlicki, ?ukasz

, p. 1346 - 1350 (2017)

Covalent enzyme inhibitors constitute a highly important group of biologically active compounds, with numerous drugs available on the market. Although the discovery of inhibitors of urease, a urea hydrolyzing enzyme crucial for the survival of some human pathogens, is a field of medicinal chemistry that has grown in recent years, covalent urease inhibitors have been rarely investigated until now. Forty Michael acceptor-type compounds were screened for their inhibitory activities against bacterial urease, and several structures exhibited high potency in the nanomolar range. The correlation between chemical reactivity towards thiols and inhibitory potency indicated the most valuable compound — acetylenedicarboxylic acid, with Ki?=42.5 nM and logkGSH=-2.14. Molecular modelling studies revealed that acetylenedicarboxylic acid is the first example of highly effective mode of binding based on simultaneous bonding to a cysteine residue and interaction with nickel ions present in the active site. Activity-reactivity profiling of reversible covalent enzyme inhibitors is a general method for the identification of valuable drug candidates.

Purification and characterization of a lyase from the EDTA-degrading bacterial strain DSM 9103 that catalyzes the splitting of [S,S]-ethylenediaminedisuccinate, a structural isomer of EDTA

Witschel, Margarete,Egli, Thomas

, p. 419 - 428 (1997)

The bacterial strain DSM 9103, able to utilize EDTA as a sole source of carbon, nitrogen, and energy, is also capable to grow with [S,S]-ethylenediaminedisuccinate ([S,S]-EDDS), a structural isomer of EDTA. In cell-free extracts of [S,S]-EDDS-grown bacteria, [S,S]-EDDS degradation was observed in the absence of any cofactors. An enzyme was purified 41-fold that catalyzed the non-hydrolytic splitting of [S,S]-EDDS leading to the formation of fumarate and N-(2-aminoethyl) aspartic acid. These data strongly suggest that the enzyme belongs to the group of carbon-nitrogen lyases. The splitting reaction was reversible, and an equilibrium constant of approximately 43.0 10-1 M was determined. Out of the three stereo-isomers of EDDS, [S,S]- and [R,S]-EDDS were accepted as substrates by the lyase, whereas [R,R]-EDDS remained unchanged in assays with both cell-free extracts and pure enzyme. The enzyme catalyzed the transformation of free [S,S]-EDDS and of [S,S]-EDDS-metal complexes with stability constant lower than 10, namely of MgEDDS, CaEDDS, BaEDDS and to a small extent also of MnEDDS; Fe(III)EDDS, NiEDDS, CuEDDS, CoEDDS and ZnEDDS were not transformed.

Structural and kinetic studies on adenylosuccinate lyase from Mycobacterium smegmatis and Mycobacterium tuberculosis provide new insights on the catalytic residues of the enzyme

Banerjee, Sanchari,Agrawal, Monika J.,Mishra, Diptimayee,Sharan, Siddharth,Balaram, Hemalatha,Savithri, Handanhal S.,Murthy, Mathur R. N.

, p. 1642 - 1658 (2014)

Adenylosuccinate lyase (ASL), an enzyme involved in purine biosynthesis, has been recognized as a drug target against microbial infections. In the present study, ASL from Mycobacterium smegmatis (MsASL) and Mycobacterium tuberculosis (MtbASL) were cloned, purified and crystallized. The X-ray crystal structure of MsASL was determined at a resolution of 2.16 A. It is the first report of an apo-ASL structure with a partially ordered active site C3 loop. Diffracting crystals of MtbASL could not be obtained and a model for its structure was derived using MsASL as a template. These structures suggest that His149 and either Lys285 or Ser279 of MsASL are the residues most likely to function as the catalytic acid and base, respectively. Most of the active site residues were found to be conserved, with the exception of Ser148 and Gly319 of MsASL. Ser148 is structurally equivalent to a threonine in most other ASLs. Gly319 is replaced by an arginine residue in most ASLs. The two enzymes were catalytically much less active compared to ASLs from other organisms. Arg319Gly substitution and reduced flexibility of the C3 loop might account for the low catalytic activity of mycobacterial ASLs. The low activity is consistent with the slow growth rate of Mycobacteria and their high GC containing genomes, as well as their dependence on other salvage pathways for the supply of purine nucleotides.

Microflow photochemistry - A reactor comparison study using the photochemical synthesis of terebic acid as a model reaction

Aida, Shin,Terao, Kimitada,Nishiyama, Yasuhiro,Kakiuchi, Kiyomi,Oelgem?ller, Michael

, p. 5578 - 5581 (2012)

The continuous-microflow photochemical synthesis of terebic acid from maleic acid was investigated in two different microreactor set-ups. The results were subsequently compared to analogue experiments in a conventional chamber reactor. Based on conversion rates, reactor design and energy efficiency calculations, the simple microcapillary reactor showed the best overall performance.

Mechanism of the Enzymic Elimination of Ammonia from 3-Substituted Aspartic Acids by 3-Methylaspartase

Botting, Nigel P.,Akhtar, Mahmoud,Cohen, Mark A.,Gani, David

, p. 1371 - 1373 (1987)

Kinetic experiments with 3-methylaspartase, using aspartic, 3-methylaspartic, and 3-ethylaspartic acid and the appropriate C-3 deuteriated isotopomers as substrates, reveal that C(3)-H bond cleavage is partially rate-limiting for 3-methylaspartic acid, much less rate-limiting for 3-ethylaspartic acid, and not rate-limiting at all for aspartic acid.

The 3-methylaspartase reaction probed using 2H- and 15N-Isotope effects for three substrates: A flip from a concerted to a carbocationic amino-enzyme elimination mechanism upon changing the C-3 stereochemistry in the substrate from R to S

Gani, David,Archer, Catherine H.,Botting, Nigel P.,Pollard, John R.

, p. 977 - 990 (1999)

The mechanisms of the elimination of ammonia from (2S,3S)-3-methylaspartic acid, (2S)-aspartic acid and (2S,3R)-3-methylaspartic acid, catalysed by the enzyme l-threo-3-methylaspartase ammonia-lyase (EC 4.3.1.2) have been probed using 15N-isotope effects. The 15N-isotope effects for V/K for both (2S,3S)-3-methylaspartic acid and aspartic acid are 1.0246±0.0013 and 1.0390±0.0031, respectively. The natural substrate, (2S,3S)-3-methylaspartic acid, is eliminated in a concerted fashion such that the C(β)-H and C(α)-N bonds are cleaved in the same transition state. (2S)-Aspartic acid appears to follow the same mechanistic pathway, but deprotonation of the conjugate acid of the base for C-3 is kinetically important and influences the extent of 15N-fractionation. (2S,3R)-3-Methylaspartic acid is deaminated via a stepwise carbocationic mechanism. Here we elaborate on the proposed model for the mechanism of methylaspartase and propose that a change in stereochemistry of the substrate induces a change in the mechanism of ammonia elimination. Copyright (C) 1999 Elsevier Science B.V.

ELIMINATION OF HYDROGEN FLUORIDE FROM FLUORINATED SUCCINIC ACIDS.(II) KINETICS OF DEHYDROFLUORINATION OF FLUORO-, 2,2-DIFLUORO-, MESO- AND DL-2,3-DIFLUORO-, AND TRIFLUOROSUCCINIC ACIDS

Hudlicky, M.,Glass, T. E.

, p. 15 - 28 (1983)

Elimination of hydrogen fluoride from fluorosuccinic acid gave fumaric acid, from 2,2-difluorosuccinic acid, meso- and DL-2,3-difluorosuccinic acid fluorofumaric acid, and dehydrofluorination of trifluorosuccinic acid afforded difluoromaleic acid.Kinetic data based on 1H NMR measurements are presented for temperatures of 60 deg C, 75 deg C and 90 deg C.All the dehydrofluorinations follow second order kinetics.Activation energies for the dehydrofluorination of the above acids were found to be: 19.3, 17.3, 18.8, 17.9 and 18.3 kcal, respectively.Since both diastereomeric 2,3-difluorosuccinic acids give fluorofumaric acid as the only product of dehydrofluorination, one of them (DL) undergoes trans elimination while the other (meso) must undergo cis elimination.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 110-17-8